MedPath
NMPA Approval

Dexrazoxane for Injection

国药准字H20244666

August 20, 2024

Drug Information

注射用右雷佐生

注射剂

500mg

化学药品

August 20, 2024

Company Information

Applicant Company

石家庄经济技术开发区扬子路88号

Manufacturing Company

石家庄经济技术开发区扬子路88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用右雷佐生 - NMPA 批准文号 | MedPath